I thank my friend for yielding to me. I rise in strong support of S. 3187, the Food and Drug Administration Safety and Innovation Act of 2012. This is one of these rare occasions these days when Congress is working in a bipartisan manner to get good things done. This bipartisan, bicameral agreement is something of which we can all be proud; and it is a prime example, again, of the good legislative work that can be done by this body when compromises are accepted. In particular, I would like to thank the chairmen and ranking members of the full Energy and Commerce Committee and of the Health Subcommittee for their hard work to finalize this bill in such a timely manner. I would also like to thank them for including the reauthorization of the Critical Path Public-Private Partnerships in this legislation, something for which I pushed for a long time so that needed improvements in regulatory science can continue. I believe this bill will help meet the needs of the FDA industry and, most importantly, of the patients. I look forward to its passage.
Share & report
More from Eliot Engel
We are here this afternoon so that this body can exercise one of its most important constitutional responsibilities, deciding on whether or not this country will wage war, whether or not we will check an executive that has brought our…
Again, I think it would be helpful if peoples' motives or patriotism wasn't questioned. Mr. Speaker, I yield 2 minutes to the gentleman from Illinois (Mr. Schneider).
Let me just say that the President always has a legal right to defend America, U.S. forces and embassies, and this resolution explicitly exempts the defensive actions described in the War Powers Resolution. The War Powers Resolution has…
On that I demand the yeas and nays. The yeas and nays were ordered. The SPEAKER pro tempore. Pursuant to clause 9 of rule XX, this 15- minute vote on adoption of H. Con. Res. 83 will be followed by a 5- minute vote on the motion to suspend…





